RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Patricia Mendonca to Antineoplastic Agents

Back to Details
This is a "connection" page, showing publications Patricia Mendonca has written about Antineoplastic Agents.
Patricia Mendonca
Connection Strength
0.350
Antineoplastic Agents
  1. Mishra SD, Mendonca P, Kaur S, Soliman KFA. Silibinin Anticancer Effects Through the Modulation of the Tumor Immune Microenvironment in Triple-Negative Breast Cancer. Int J Mol Sci. 2025 Jun 28; 26(13).
    View in: PubMed
    Score: 0.130
  2. Adinew GM, Taka E, Mendonca P, Messeha SS, Soliman KFA. The Anticancer Effects of Flavonoids through miRNAs Modulations in Triple-Negative Breast Cancer. Nutrients. 2021 Apr 07; 13(4).
    View in: PubMed
    Score: 0.097
  3. Messeha SS, Zarmouh NO, Mendonca P, Cotton C, Soliman KFA. Molecular mechanism of gossypol mediating CCL2 and IL-8 attenuation in triple-negative breast cancer cells. Mol Med Rep. 2020 08; 22(2):1213-1226.
    View in: PubMed
    Score: 0.092
  4. Kaur S, Mendonca P, Soliman KFA. The Anticancer Effects and Therapeutic Potential of Kaempferol in Triple-Negative Breast Cancer. Nutrients. 2024 Jul 23; 16(15).
    View in: PubMed
    Score: 0.031
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support